The global IV poles market is valued at US$ 1.90 billion in 2026 and is projected to reach US$ 2.88 billion by 2033, growing at a 6.1% CAGR.
Market growth is driven by expanding chronic disease treatment infrastructure and increasing adoption of ergonomic and safety-compliant medical equipment.
Mobile IV Poles lead the market with a 62.8% share, owing to their essential role in enabling uninterrupted infusion therapy during patient movement.
North America dominates the market with a 38.7% share in 2026, supported by advanced hospital infrastructure and centralized procurement systems.
The most significant opportunity lies in lightweight, home-use IV poles, fueled by the growing adoption of home infusion therapy and supportive reimbursement policies.